H.I.S. Co., Ltd. Logo

H.I.S. Co., Ltd.

A major Japanese travel agency providing global tour packages, lodging, and transport.

9603 | T

Overview

Corporate Details

ISIN(s):
JP3160740001
LEI:
Country:
Japan
Address:
港区虎ノ門四丁目1番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

H.I.S. Co., Ltd. is a major Japanese travel agency established in 1980. The company initially distinguished itself by pioneering the sale of low-cost airline tickets in Japan. Its primary operations involve providing a wide range of travel services, including domestic and international tour packages, lodging, and transportation solutions. The H.I.S. Group has expanded its business portfolio to include hotel operations, regional revitalization projects, and specialized inbound tourism services. With a global network, it is recognized as one of Japan's leading travel organizations, catering to a diverse clientele worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-13 08:36
Regulatory News Service
確認書
Japanese 8.1 KB
2025-06-13 08:34
Interim Report
半期報告書-第45期(2024/11/01-2025/10/31)
Japanese 247.2 KB
2025-06-05 10:02
Regulatory News Service
臨時報告書
Japanese 19.6 KB
2025-05-23 08:31
Regulatory News Service
臨時報告書
Japanese 19.0 KB
2025-05-20 09:21
M&A Activity
臨時報告書
Japanese 19.7 KB
2025-04-30 08:32
Regulatory News Service
臨時報告書
Japanese 19.8 KB
2025-03-31 10:14
Legal Proceedings Report
臨時報告書
Japanese 21.7 KB
2025-03-31 10:05
Regulatory News Service
臨時報告書
Japanese 19.6 KB
2025-03-31 09:57
Governance Information
内部統制報告書-第44期(2023/11/01-2024/10/31)
Japanese 44.9 KB
2025-03-31 09:56
Registration Form
確認書
Japanese 8.1 KB
2025-03-31 09:55
Annual Report
有価証券報告書-第44期(2023/11/01-2024/10/31)
Japanese 2.1 MB
2025-03-31 09:40
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-03-31 09:39
Quarterly Report
訂正四半期報告書-第44期第2四半期(2024/02/01-2024/04/30)
Japanese 305.5 KB
2025-03-31 09:38
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-03-31 09:37
Quarterly Report
訂正四半期報告書-第44期第1四半期(2023/11/01-2024/01/31)
Japanese 249.1 KB

Automate Your Workflow. Get a real-time feed of all H.I.S. Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for H.I.S. Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for H.I.S. Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Optipharm.CO.,LTD Logo
Biotech for animal health and xenotransplantation using genetically engineered pig organs.
South Korea 153710
Organoid-based platforms for drug testing and regenerative therapeutics.
South Korea 476040
Oricon Inc. Logo
Provides entertainment industry data, music charts, web media, and marketing services.
Japan 4800
ORIENTBIO Inc. Logo
Provides animal models & technical services for preclinical R&D to pharma & research institutions.
South Korea 002630
Oryzon Genomics S.A. Logo
Develops epigenetic-based medicines for cancer and central nervous system disorders.
Spain ORY
OSCOTECInc. Logo
A clinical-stage drug discovery company developing innovative medicines for unmet needs.
South Korea 039200
OSE Immunotherapeutics Logo
Develops first-in-class immune therapies for oncology and inflammation, partnering for late-stage.
France OSE
Oxurion NV Logo
Acquires European pharmaceutical subcontractors to build an integrated healthcare services group.
Belgium OXUR
PA Co., Ltd Logo
Offers HR solutions like recruitment media, staffing, and childcare to revitalize local communities.
Japan 4766
PCI Biotech Holding Logo
Biopharma firm evaluating its future after discontinuing its core technology development.
Norway PCIB

Talk to a Data Expert

Have a question? We'll get back to you promptly.